BDX Insider Trading

Insider Ownership Percentage: 54.27%
Insider Buying (Last 12 Months): A$92,624.60
Insider Selling (Last 12 Months): A$0.00

BCAL Diagnostics Insider Trading History Chart

This chart shows the insider buying and selling history at BCAL Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BCAL Diagnostics Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 09/9/2021 10:05 AM ET

This chart shows the closing price history over time for BDX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

BCAL Diagnostics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/14/2024Jayne ShawInsiderBuy725,000A$0.11A$76,850.00
11/24/2023Mark BurrowsInsiderIssued300,000A$0.10A$30,000.00
9/18/2023Ronald (Ron) PhillipsInsiderBuy157,746A$0.10A$15,774.60
5/2/2023Merilyn SleighInsiderBuy45,000A$0.09A$4,095.00
7/1/2022Jayne ShawInsiderBuy410,035A$0.08A$31,162.66
12/9/2021Mark BurrowsInsiderBuy357,142A$0.14A$49,999.88
9/6/2021Jayne ShawInsiderBuy180,000A$0.20A$36,000.00
See Full Table

SEC Filings (Institutional Ownership Changes) for BCAL Diagnostics (ASX:BDX)

4.97% of BCAL Diagnostics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

BCAL Diagnostics logo
BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a non-invasive blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from patient's blood plasma to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
Read More on BCAL Diagnostics

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.31

Who are the company insiders with the largest holdings of BCAL Diagnostics?

BCAL Diagnostics' top insider investors include:
  1. Jayne Shaw (Insider)
  2. Mark Burrows (Insider)
  3. Merilyn Sleigh (Insider)
  4. Ronald (Ron) Phillips (Insider)
Learn More about top insider investors at BCAL Diagnostics.